后新冠时代的心血管疾病负担

The Burden of Cardiovascular Disease in the Post-COVID Era.

机构信息

Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, 60 Haven Avenue (Tower 1), Level B2 (Lobby Level) - Office Suite B234, New York, NY 10032, USA.

出版信息

Prim Care. 2024 Mar;51(1):1-11. doi: 10.1016/j.pop.2023.08.001. Epub 2023 Sep 1.

DOI:10.1016/j.pop.2023.08.001

PMID:38278564

Abstract

In 2019, before the COVID-19 pandemic, cardiovascular disease (CVD) was the leading cause of death. Since 2020, the pandemic has had far-reaching effects on the landscape of health care including CVD prevention and management. Recent decreases in life expectancy in the United States could potentially be explained by issues related to disruptions in CVD prevention and control of CVD risk factors from the COVID-19 pandemic. This article reviews the effects of the SARS-CoV-2 virus and the accompanying pandemic on CVD risk factor prevention and management in the United States. Potential solutions are also proposed for these patients.

摘要

2019 年，在 COVID-19 大流行之前，心血管疾病（CVD）是导致死亡的主要原因。自 2020 年以来，大流行对医疗保健领域产生了深远的影响，包括 CVD 的预防和管理。最近美国预期寿命的下降可能与 COVID-19 大流行导致的 CVD 预防和 CVD 危险因素控制方面的问题有关。本文综述了 SARS-CoV-2 病毒及其伴随的大流行对美国 CVD 危险因素预防和管理的影响。还为这些患者提出了潜在的解决方案。